Switch to:
Nivalis Therapeutics Inc (NAS:NVLS)
Cash to Debt Ratio
No Debt (As of Mar. 2015)

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash and cash equivalents divide by its debt. Nivalis Therapeutics Inc's cash to debt ratio for the quarter that ended in Mar. 2015 was No Debt.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Nivalis Therapeutics Inc could pay off its debt using the cash in hand for the quarter that ended in Mar. 2015.

NVLS' s 10-Year Cash to Debt Range
Min: 0   Max: 0
Current: 0

NVLS's Cash to Debtis ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. NVLS: 0.00 )

Definition

This is the ratio of a company's Cash and cash equivalents to its debt. The debt includes the Current Portion of Long-Term Debt and Long-Term Debt. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Nivalis Therapeutics Inc's Cash to Debt Ratio for the fiscal year that ended in Dec. 2014 is calculated as:

Nivalis Therapeutics Inc had no debt.

Nivalis Therapeutics Inc's Cash to Debt Ratio for the quarter that ended in Mar. 2015 is calculated as:

Nivalis Therapeutics Inc had no debt.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Related Terms

Current Portion of Long-Term Debt, Long-Term Debt, Cash and Cash Equivalents (For Banks and Insurance Companies), Cash and Cash Equivalents, Interest Coverage


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Nivalis Therapeutics Inc Annual Data

Dec12Dec13Dec14
cash2debt 0.000.000.000.000.000.000.00N/A0.07No Debt

Nivalis Therapeutics Inc Semi-Annual Data

Dec12Dec13Mar14Dec14Mar15
cash2debt 0.000.000.000.000.00N/AN/AN/AN/ANo Debt
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK